ADJUVANT TASHNIIVS is being used in the production of vaccines. It is intended for use in the production of vaccines including against
COVID-19, as a substitute or use of its percentage content to increase vaccines immunogenicity tenfold. Raw material: Products of
lymphoid tissue and its concentrated solutions.